New Drug Development & Regulatory News
Sirnaomics announces completion of IND-Enabling studies of safety and efficacy for STP125G with NHP models
Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G. Read more
24 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Novogene to power cancer, rare disease, and environmental research with PacBio Sequencing
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany. Read more
23 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
SynaptixBio and Evotec extend collaboration to boost search for rare disease therapies
SynaptixBio has announced it is extending its collaboration agreement with Evotec to find further candidate drugs to treat H-ABC, the most severe form of TUBB4A leukodystrophy. Read more
22 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Upperton Pharma Solutions adds large-scale processing after MHRA approval at Nottingham facility
Upperton Pharma Solutions has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and GMP manufacturing facility in Nottingham, UK. Read more
16 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
NICE recommends Ebglyss for use in moderate to severe Atopic Dermatitis in NHS England
Almirall S.A. a global biopharmaceutical company dedicated to medical dermatology, has announced that NICE has recommended Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England. Read more
10 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
SMART researchers pioneer production of CAR T-Cells using high-density microfluidic bioreactor
Researchers from the CAMP IRG at Singapore-MIT Alliance for Research and Technology, have developed a novel method capable of producing clinical doses of viable autologous chimeric antigen receptor (CAR) T-cells. Read more
8 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Endless Health raises $4.5M series seed
Endless Health, an end-to-end at-home testing and preventive medicine company, has secured $4.5 million in a Series Seed funding round. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Genetically engineered iPSCs offer improved efficiency
AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research. Read more
23 Jul 2024
Envision Pharma Group launches 4Sight
Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimise raw data and turn it into actionable insights for healthcare professionals. Read more
18 Jul 2024
CARBOGEN AMCIS Passes Two FDA Inspections at its Manufacturing Sites in Switzerland
Both sites in Neuland and Aarau passed the inspection processes with No Actions Indicated (NAIs) identified. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Finish Thompson highlights drum pumps for pharma applications
Finish Thompson Inc. (FTI), a specialist in the corrosive chemical transfer industry, highlights its SFV drum pump, a cost-effective pump designed for container-to-container transfer of acids, corrosives, and chemicals. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
LYVA Labs' Innovate UK Biomedical Catalyst Microbials Accelerator companies secure £857,000 in funding
Nine innovative businesses have received receiving £857k in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’ Microbials Accelerator programme - the first Innovate UK programme of its kind in this field. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Broken String Biosciences Appoints New Chief Commercial Officer
The newly appointed Steve Becker will help guide the genomics company as it expands its commercial operations. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sirnaomics announces completion of IND-Enabling studies of safety and efficacy for STP125G with NHP models
Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G. Read more
24 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Enterprise Therapeutics Doses First Person with Cystic Fibrosis with ETD001
As part of the Phase 2a trial, ETD001 aims to clear mucus and increase hydration by targeting the epithelial sodium channel. Read more
24 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News